Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Giustino Parruti and Ettore Porreca.
Giustino Parruti
Connection Strength
1.124
Ettore Porreca
  1. Interleukin-6 receptor blockade with subcutaneous tocilizumab improves coagulation activity in patients with COVID-19. Eur J Intern Med. 2021 01; 83:34-38.
    View in: PubMed
    Score: 0.228
  2. Response to: 'Correspondence on 'Interleukin-6 blockade with subcutaneous tocilizumab in severe COVID-19 pneumonia and hyperinflammation: a case-control study' by Potere et al' by Buckley. Ann Rheum Dis. 2020 Sep 01.
    View in: PubMed
    Score: 0.225
  3. Low-dose subcutaneous tocilizumab to prevent disease progression in patients with moderate COVID-19 pneumonia and hyperinflammation. Int J Infect Dis. 2020 Nov; 100:421-424.
    View in: PubMed
    Score: 0.224
  4. Response to: 'Rational use of tocilizumab in COVID-19' by Jain and Sharma. Ann Rheum Dis. 2020 Jul 31.
    View in: PubMed
    Score: 0.224
  5. Interleukin-6 receptor blockade with subcutaneous tocilizumab in severe COVID-19 pneumonia and hyperinflammation: a case-control study. Ann Rheum Dis. 2021 02; 80(2):1-2.
    View in: PubMed
    Score: 0.223
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.